AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Immunic Stock Soars 23.53% on Wedbush Target Cut
Generated by AI AgentAinvest Pre-Market Radar
Friday, May 30, 2025 6:02 am ET1min read
On May 30, 2025, Immunic's stock surged by 23.53% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.
Immunic's stock price target was recently adjusted by Wedbush, reducing it from $61 to $14. This revision comes after the company was initially rated as "outperform" with a $40 stock price target. The change in target price reflects the evolving market sentiment and potential challenges the company may face in the near future.
Despite the recent volatility,
continues to be a focal point for investors, with its innovative approach to biotechnology and potential breakthroughs in the field of immunology. The company's strategic initiatives and partnerships are expected to drive future growth and stability, making it a stock to watch in the coming months.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Metallus shares plunge 6.73% as investor concerns over earnings volatility and sector risks grow
Dec.22 2025
Annexon (ANNX) Surges 7.26% in Pre-Market Trading After S&P Biotechnology Index Inclusion
Dec.22 2025
Aeva Technologies Inc. surges 7.69% on strategic partnership with major automaker
Dec.22 2025
Oracle shares surge 6.63% on OpenAI rebuttal and healthcare contracts
Dec.22 2025
Broadcom Inc. (NASDAQ:AVGO) surges 3.18% on analyst upgrades amid AI growth optimism
Dec.22 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet